Mechanism of insulin receptor kinase inhibition in non-insulin-dependent diabetes mellitus patients. Phosphorylation of serine 1327 or threonine 1348 is unaltered - PubMed (original) (raw)
Mechanism of insulin receptor kinase inhibition in non-insulin-dependent diabetes mellitus patients. Phosphorylation of serine 1327 or threonine 1348 is unaltered
M Kellerer et al. J Clin Invest. 1995 Jul.
Abstract
The tyrosine kinase activity of insulin receptor isolated from the skeletal muscle of NIDDM patients has previously been found to be decreased compared with the activity of receptor from nondiabetic subjects but the mechanism underlying this defect is unknown. Phosphorylation of receptor serine/threonine residues has been proposed to exert an inhibitory influence on receptor tyrosine kinase activity and Ser 1327 and Thr 1348 have been identified as specific sites of phosphorylation in the insulin receptor COOH terminal domain. To address the potential negative regulatory role of phosphorylation of these residues in vivo, we assessed the extent of phosphorylation of each site in insulin receptor isolated from the skeletal muscle of 12 NIDDM patients and 13 nondiabetic, control subjects. Phosphorylation of Ser 1327 and Thr 1348 was determined using antibodies that specifically recognize insulin receptor phosphorylated at these sites. In addition, a phosphotyrosine-specific antibody was used to monitor receptor tyrosine phosphorylation. The extent of insulin-induced tyrosine autophosphorylation was decreased in receptor isolated from diabetic versus nondiabetic muscle, thus confirming earlier reports. In contrast, there was no significant difference in the extent of phosphorylation of either Ser 1327 or Thr 1348 in receptor isolated from diabetic or nondiabetic muscle as assessed by immunoprecipitation (Ser 1327: 5.6 +/- 1.6% diabetics vs. 4.7 +/- 2.0% control; Thr 1348: 3.8 +/- 1.0% diabetics vs. 3.2 +/- 1.2% control). Moreover, within each group there was no correlation between the level of tyrosine kinase activity and the extent of serine/threonine phosphorylation. It is concluded that the stoichiometry of serine/threonine phosphorylation of insulin receptor in vivo is low, and that increased phosphorylation of Ser 1327 or Thr 1348 is not responsible for the decreased insulin receptor tyrosine kinase activity observed in the skeletal muscle of NIDDM patients.
Similar articles
- Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.
Dunaif A, Xia J, Book CB, Schenker E, Tang Z. Dunaif A, et al. J Clin Invest. 1995 Aug;96(2):801-10. doi: 10.1172/JCI118126. J Clin Invest. 1995. PMID: 7635975 Free PMC article. - Mechanism of defective insulin-receptor kinase activity in NIDDM. Evidence for two receptor populations.
Brillon DJ, Freidenberg GR, Henry RR, Olefsky JM. Brillon DJ, et al. Diabetes. 1989 Mar;38(3):397-403. doi: 10.2337/diab.38.3.397. Diabetes. 1989. PMID: 2465197 - Mechanism of improving effect of losartan on insulin sensitivity of non-insulin-dependent diabetes mellitus rats.
Wu Y, Ouyang JP, Zhou YF, Wu K, Zhao DH, Wen CY. Wu Y, et al. Sheng Li Xue Bao. 2004 Aug 25;56(4):539-49. Sheng Li Xue Bao. 2004. PMID: 15322693 - Uncoupling insulin signalling by serine/threonine phosphorylation: a molecular basis for insulin resistance.
Zick Y. Zick Y. Biochem Soc Trans. 2004 Nov;32(Pt 5):812-6. doi: 10.1042/BST0320812. Biochem Soc Trans. 2004. PMID: 15494022 Review.
Cited by
- Insulin Resistance, Obesity, and Lipotoxicity.
Yazıcı D, Demir SÇ, Sezer H. Yazıcı D, et al. Adv Exp Med Biol. 2024;1460:391-430. doi: 10.1007/978-3-031-63657-8_14. Adv Exp Med Biol. 2024. PMID: 39287860 Review. - Glucose-induced phosphorylation of the insulin receptor. Functional effects and characterization of phosphorylation sites.
Pillay TS, Xiao S, Olefsky JM. Pillay TS, et al. J Clin Invest. 1996 Feb 1;97(3):613-20. doi: 10.1172/JCI118457. J Clin Invest. 1996. PMID: 8609215 Free PMC article. - Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease.
Samuel VT, Liu ZX, Wang A, Beddow SA, Geisler JG, Kahn M, Zhang XM, Monia BP, Bhanot S, Shulman GI. Samuel VT, et al. J Clin Invest. 2007 Mar;117(3):739-45. doi: 10.1172/JCI30400. Epub 2007 Feb 22. J Clin Invest. 2007. PMID: 17318260 Free PMC article. - Mechanisms of Insulin Action and Insulin Resistance.
Petersen MC, Shulman GI. Petersen MC, et al. Physiol Rev. 2018 Oct 1;98(4):2133-2223. doi: 10.1152/physrev.00063.2017. Physiol Rev. 2018. PMID: 30067154 Free PMC article. Review. - Mechanisms for insulin resistance: common threads and missing links.
Samuel VT, Shulman GI. Samuel VT, et al. Cell. 2012 Mar 2;148(5):852-71. doi: 10.1016/j.cell.2012.02.017. Cell. 2012. PMID: 22385956 Free PMC article. Review.
References
- J Hypertens. 1994 Jan;12(1):81-8 - PubMed
- J Clin Endocrinol Metab. 1994 Feb;78(2):471-7 - PubMed
- Biochem J. 1994 Nov 1;303 ( Pt 3):893-9 - PubMed
- Mol Cell Endocrinol. 1994 Oct;105(1):11-20 - PubMed
- Diabetologia. 1991 Dec;34(12):848-61 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical